An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia.

Hdl Handle:
http://hdl.handle.net/10147/229048
Title:
An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia.
Authors:
Vaughan, D; Byrne, P
Affiliation:
Department of Gynaecology, Beaumont Hospital, Dublin, Ireland.
Citation:
An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia. 2012, 32 (4):372-4 J Obstet Gynaecol
Journal:
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Issue Date:
May-2012
URI:
http://hdl.handle.net/10147/229048
DOI:
10.3109/01443615.2012.666581
PubMed ID:
22519484
Abstract:
The objective of our study was to document the efficacy and possible complications in women who were treated for menorrhagia with the simultaneous use of endometrial ablation and the levonorgestrel-releasing intrauterine device. Women were offered this combined treatment if they complained of menorrhagia and needed contraception. A structured questionnaire was mailed to 150 women who had undergone this combined treatment; 105 (70%) returned a completed questionnaire. The mean duration of follow-up was 25 months (range 6-54 months). Following treatment, 53 women (50.5%) described their periods as being lighter than normal and 49 (46%) had become amenorrhoeic. Overall, 101 (96%) stated that they were satisfied with the treatment. Of the women, 95 (90.5%) said that the treatment had been a 'complete success'; eight (7.6%) 'partly successful' and two women (1.9%) said the treatment had been a 'failure'. One woman subsequently required a hysterectomy. This observational study supports the hypothesis that combined endometrial ablation and insertion of a levonorgestrel-releasing intrauterine device is an effective treatment for menorrhagia and has some advantages when compared with the individual use of these treatments.
Item Type:
Article
Language:
en
ISSN:
1364-6893

Full metadata record

DC FieldValue Language
dc.contributor.authorVaughan, Den_GB
dc.contributor.authorByrne, Pen_GB
dc.date.accessioned2012-06-15T11:26:00Z-
dc.date.available2012-06-15T11:26:00Z-
dc.date.issued2012-05-
dc.identifier.citationAn evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia. 2012, 32 (4):372-4 J Obstet Gynaecolen_GB
dc.identifier.issn1364-6893-
dc.identifier.pmid22519484-
dc.identifier.doi10.3109/01443615.2012.666581-
dc.identifier.urihttp://hdl.handle.net/10147/229048-
dc.description.abstractThe objective of our study was to document the efficacy and possible complications in women who were treated for menorrhagia with the simultaneous use of endometrial ablation and the levonorgestrel-releasing intrauterine device. Women were offered this combined treatment if they complained of menorrhagia and needed contraception. A structured questionnaire was mailed to 150 women who had undergone this combined treatment; 105 (70%) returned a completed questionnaire. The mean duration of follow-up was 25 months (range 6-54 months). Following treatment, 53 women (50.5%) described their periods as being lighter than normal and 49 (46%) had become amenorrhoeic. Overall, 101 (96%) stated that they were satisfied with the treatment. Of the women, 95 (90.5%) said that the treatment had been a 'complete success'; eight (7.6%) 'partly successful' and two women (1.9%) said the treatment had been a 'failure'. One woman subsequently required a hysterectomy. This observational study supports the hypothesis that combined endometrial ablation and insertion of a levonorgestrel-releasing intrauterine device is an effective treatment for menorrhagia and has some advantages when compared with the individual use of these treatments.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecologyen_GB
dc.titleAn evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Gynaecology, Beaumont Hospital, Dublin, Ireland.en_GB
dc.identifier.journalJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecologyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.